Published in J Cereb Blood Flow Metab on July 11, 2012
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg (2017) 1.38
Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol (2016) 1.38
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet (2013) 1.22
Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke (2012) 1.17
Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. J Neuroinflammation (2012) 1.15
Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflammation (2014) 1.15
TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab (2013) 1.05
The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res (2013) 0.99
Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results. J Am Heart Assoc (2013) 0.98
MicroRNA/mRNA profiling and regulatory network of intracranial aneurysm. BMC Med Genomics (2013) 0.96
Quantifying the large-scale hemodynamics of intracranial aneurysms. AJNR Am J Neuroradiol (2013) 0.95
Role of fluid dynamics and inflammation in intracranial aneurysm formation. Circulation (2014) 0.93
Circulating microRNAs serve as novel biological markers for intracranial aneurysms. J Am Heart Assoc (2014) 0.91
Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke (2013) 0.90
Genome-wide microRNA changes in human intracranial aneurysms. BMC Neurol (2014) 0.88
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One (2013) 0.88
Selective vulnerability of the cerebral vasculature to blast injury in a rat model of mild traumatic brain injury. Acta Neuropathol Commun (2014) 0.88
Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis (2015) 0.85
Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2015) 0.84
Factors affecting formation and rupture of intracranial saccular aneurysms. Neurosurg Rev (2013) 0.82
Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research. Mediators Inflamm (2015) 0.82
RNA-Sequencing Analysis of Messenger RNA/MicroRNA in a Rabbit Aneurysm Model Identifies Pathways and Genes of Interest. AJNR Am J Neuroradiol (2015) 0.81
Natural History of Unruptured Intracranial Aneurysms : A Retrospective Single Center Analysis. J Korean Neurosurg Soc (2016) 0.80
A critical role for proinflammatory behavior of smooth muscle cells in hemodynamic initiation of intracranial aneurysm. PLoS One (2013) 0.80
A comparative review of the hemodynamics and pathogenesis of cerebral and abdominal aortic aneurysms: lessons to learn from each other. J Cerebrovasc Endovasc Neurosurg (2014) 0.79
Endothelial cell high-enrichment from endovascular biopsy sample by laser capture microdissection and fluorescence activated cell sorting. J Biotechnol (2014) 0.79
Inflammation and human cerebral aneurysms: current and future treatment prospects. Future Neurol (2013) 0.78
Biology of Saccular Cerebral Aneurysms: A Review of Current Understanding and Future Directions. Front Surg (2016) 0.78
Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms. Hypertension (2014) 0.78
Estrogen signaling through estrogen receptor beta and G-protein-coupled estrogen receptor 1 in human cerebral vascular endothelial cells: implications for cerebral aneurysms. Biomed Res Int (2013) 0.77
Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis. Meta Gene (2016) 0.77
Site-specific elevation of interleukin-1β and matrix metalloproteinase-9 in the Willis circle by hemodynamic changes is associated with rupture in a novel rat cerebral aneurysm model. J Cereb Blood Flow Metab (2016) 0.77
Potential role of granulocyte-monocyte colony-stimulating factor in the progression of intracranial aneurysms. DNA Cell Biol (2015) 0.76
Body pigmentation as a risk factor for the formation of intracranial aneurysms. Biomed Res Int (2014) 0.76
Curvature effect on hemodynamic conditions at the inner bend of the carotid siphon and its relation to aneurysm formation. J Biomech (2014) 0.75
Evidence That a Subset of Aneurysms Less Than 7 mm Warrant Treatment. J Am Heart Assoc (2016) 0.75
Endovascular biopsy: Strategy for analyzing gene expression profiles of individual endothelial cells obtained from human vessels(✩). Biotechnol Rep (Amst) (2015) 0.75
Echocardiographic evidence of innate aortopathy in the human intracranial aneurysm. PLoS One (2014) 0.75
Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells. J Neuroinflammation (2016) 0.75
Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension (2016) 0.75
Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med (2016) 0.75
Coexistence of intracranial epidermoid tumor and multiple cerebral aneurysms: A case report and literature review. Medicine (Baltimore) (2017) 0.75
Fatal Thrombosis of a Flow Diverter due to Ibuprofen-related Antagonization of Acetylsalicylic Acid. Clin Neuroradiol (2015) 0.75
For Whom the Bell Tolls (and Nods): Spit-acular Saliva. Curr Trop Med Rep (2016) 0.75
Identification of crucial genes in intracranial aneurysm based on weighted gene coexpression network analysis. Cancer Gene Ther (2015) 0.75
[Intensive care treatment after aneurysmal subarachnoid hemorrhage]. Anaesthesist (2016) 0.75
Comparison between smaller ruptured intracranial aneurysm and larger un-ruptured intracranial aneurysm: gene expression profile analysis. Neurosurg Rev (2016) 0.75
Upregulation of HMGB1 in wall of ruptured and unruptured human cerebral aneurysms: preliminary results. Neurol Sci (2015) 0.75
The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-κB, MCP-1 and MMP-9. Exp Ther Med (2017) 0.75
Screening of Critical Genes and MicroRNAs in Blood Samples of Patients with Ruptured Intracranial Aneurysms by Bioinformatic Analysis of Gene Expression Data. Med Sci Monit (2017) 0.75
Downregulation of T cell immunoglobulin and mucin protein 3 in the pathogenesis of intracranial aneurysm. Inflammation (2015) 0.75
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med (1998) 8.63
Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev (2006) 5.27
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem (2008) 4.08
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke (2007) 3.59
Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol (2009) 3.05
Inflammation in atherosclerosis: transition from theory to practice. Circ J (2010) 2.98
Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke (2007) 2.58
Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke (2004) 2.53
Are aortic aneurysms caused by atherosclerosis? Circulation (1992) 2.52
Molecular determinants of vascular smooth muscle cell diversity. Circ Res (2005) 2.33
Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke (1999) 2.10
Adaptive immunity and atherosclerosis. Clin Immunol (2009) 2.08
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke (2011) 2.07
Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery (2003) 2.07
Genomics of human intracranial aneurysm wall. Stroke (2009) 2.06
Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.98
Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol (2000) 1.94
Effects of arterial geometry on aneurysm growth: three-dimensional computational fluid dynamics study. J Neurosurg (2004) 1.91
Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet (2008) 1.90
Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke (2001) 1.87
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke (1998) 1.77
Inflammation and intracranial aneurysms. Neurosurgery (1999) 1.74
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol (2004) 1.70
Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke (2008) 1.67
Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke (2008) 1.64
Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis (2002) 1.63
Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol (2002) 1.62
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol (2011) 1.57
Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke (2006) 1.56
Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation (2000) 1.50
Correlation between lumenal geometry changes and hemodynamics in fusiform intracranial aneurysms. AJNR Am J Neuroradiol (2005) 1.50
Histologic and morphologic comparison of experimental aneurysms with human intracranial aneurysms. AJNR Am J Neuroradiol (1998) 1.49
Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke (2009) 1.45
Do statins reduce the risk of aneurysm development? A case-control study. J Neurosurg (2011) 1.45
Mouse model of cerebral aneurysm: experimental induction by renal hypertension and local hemodynamic changes. Stroke (2002) 1.41
Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol (2005) 1.40
The critical role of hemodynamics in the development of cerebral vascular disease. J Neurosurg (2010) 1.40
Innate and adaptive immunity in atherosclerosis. Semin Immunopathol (2009) 1.40
NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation (2007) 1.39
Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery (1997) 1.36
PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol (2011) 1.34
The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology (2007) 1.33
Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand (1998) 1.32
Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. Am J Physiol (1997) 1.32
TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag (2008) 1.31
Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp (2007) 1.28
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci (2005) 1.25
Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension (2002) 1.21
Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery (2005) 1.20
An animal model of cerebral aneurysms. Neuropathol Appl Neurobiol (1987) 1.20
The human mast cell: an overview. Methods Mol Biol (2006) 1.17
Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J Neurosurg (2007) 1.17
Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol (1994) 1.16
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Cerebral aneurysms arising at nonbranching sites. An experimental Study. Stroke (1997) 1.12
Intracranial aneurysms: flow analysis of their origin and progression. AJNR Am J Neuroradiol (1992) 1.12
Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg (2009) 1.12
Network-based gene expression analysis of intracranial aneurysm tissue reveals role of antigen presenting cells. Neuroscience (2008) 1.11
Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol (2006) 1.11
Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery (2006) 1.11
Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke (2007) 1.10
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab (2009) 1.10
Progressive aneurysm development following hemodynamic insult. J Neurosurg (2010) 1.07
Experimentally induced cerebral aneurysms in rats: Part VI. Hypertension. Surg Neurol (1980) 1.07
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol (2007) 1.07
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediators Inflamm (2009) 1.05
Roles of macrophages in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab (2008) 1.05
Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? Stroke (2009) 1.05
Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab (2001) 1.04
Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular (2009) 1.04
Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab (2005) 1.04
The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry (2006) 1.02
Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery (2005) 1.01
Cellular and molecular responses of the basilar terminus to hemodynamics during intracranial aneurysm initiation in a rabbit model. J Vasc Res (2011) 1.01
Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery (2006) 1.01
Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol (1999) 1.00
Endothelial cell layer subjected to impinging flow mimicking the apex of an arterial bifurcation. Ann Biomed Eng (2008) 1.00
Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol (2000) 1.00
Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats. J Hypertens (2010) 1.00
Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. J Biol Regul Homeost Agents (2010) 0.99
The development and the use of experimental animal models to study the underlying mechanisms of CA formation. J Biomed Biotechnol (2010) 0.98
Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab Invest (2009) 0.98
Contribution of mast cells to cerebral aneurysm formation. Curr Neurovasc Res (2010) 0.97
Complement system becomes activated by the classical pathway in intracranial aneurysm walls. Lab Invest (2009) 0.97
Effect of spatial gradient in fluid shear stress on morphological changes in endothelial cells in response to flow. Biochem Biophys Res Commun (2010) 0.96
Tumor necrosis factor-alpha gene and cerebral aneurysms. Neurosurgery (2007) 0.96
Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation. Neurosurgery (2009) 0.96
Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke (2006) 0.96
Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 0.95
Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part II: experimental study of the effects of hormone replacement therapy in rats. J Neurosurg (2005) 0.94
Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J Hypertens (2009) 0.94
Ethanol modulation of TNF-alpha biosynthesis and signaling in endothelial cells: synergistic augmentation of TNF-alpha mediated endothelial cell dysfunctions by chronic ethanol. Alcohol Clin Exp Res (2005) 0.93
Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Neurosurgery (2009) 0.93
Histological analysis of clipped human intracranial aneurysms and parent arteries with short-term follow-up. Cardiovasc Pathol (2011) 0.93
Seven-transmembrane-spanning receptors and heart function. Nature (2002) 5.38
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation (2002) 3.15
A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res (2010) 3.00
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell (2007) 2.65
Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery (2004) 2.56
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med (2007) 2.48
A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest (2003) 2.32
Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res (2012) 2.31
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J (2005) 2.29
Endovascular treatment of proximal and distal posterior inferior cerebellar artery aneurysms. J Neurosurg (2013) 2.23
G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res (2008) 2.22
Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation (2008) 2.17
Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ Res (2012) 2.16
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation (2003) 2.16
Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol (2003) 2.08
Subarachnoid hemorrhage due to isolated spinal artery aneurysm in four patients. AJNR Am J Neuroradiol (2005) 2.08
Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling. Circ Res (2006) 2.08
Aneurysmal subarachnoid hemorrhage in patients under 35-years-old: a single-center experience. Clin Neurol Neurosurg (2012) 2.01
Cerebrospinal fluid drainage and induced hypertension improve spinal cord perfusion after acute spinal cord injury in pigs. Neurosurgery (2015) 1.97
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci U S A (2008) 1.93
C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation (2012) 1.90
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension (2013) 1.83
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke (2011) 1.83
Gene therapy in heart failure. Circ Res (2008) 1.79
Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci U S A (2004) 1.76
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation (2006) 1.73
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation (2007) 1.73
Standards for reporting randomized controlled trials in neurosurgery. J Neurosurg (2010) 1.71
Treatment of posterior circulation aneurysms with the pipeline embolization device. Neurosurgery (2013) 1.69
Long-term outcomes and prognostic factors in pediatric patients with severe traumatic brain injury and elevated intracranial pressure. J Neurosurg Pediatr (2008) 1.69
S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol (2011) 1.68
Perioperative management of patients undergoing transsphenoidal pituitary surgery. Anesth Analg (2005) 1.66
Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article. J Neurosurg (2009) 1.66
β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ Res (2012) 1.66
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation (2006) 1.64
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63
Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res (2013) 1.62
β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing. Circ Res (2013) 1.59
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest (2004) 1.58
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery (2010) 1.56
Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.56
Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress. Circulation (2008) 1.56
Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med (2011) 1.54
Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke (2013) 1.54
Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ Res (2010) 1.52
Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction. Circulation (2012) 1.52
Direct evidence of intracrine angiotensin II signaling in neurons. Am J Physiol Cell Physiol (2014) 1.51
Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med (2011) 1.50
Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience. World Neurosurg (2012) 1.50
Moyamoya disorder in the United States. Neurosurgery (2012) 1.50
Anterior-to-posterior circulation approach for mechanical thrombectomy of an acutely occluded basilar artery using the penumbra aspiration system. World Neurosurg (2011) 1.48
Is packing density important in stent-assisted coiling? Neurosurgery (2012) 1.47
Influence of weekend hospital admission on short-term mortality after intracerebral hemorrhage. Stroke (2009) 1.46
Stent-assisted endovascular recanalization of extracranial internal carotid artery occlusion in acute ischemic stroke. World Neurosurg (2012) 1.44
Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery (2012) 1.43
Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem (2003) 1.43
A novel endovascular technique for temporary balloon occlusion and permanent vessel deconstruction with a single microcatheter. World Neurosurg (2012) 1.42
Spontaneous systolic blood pressure elevation during temporary balloon occlusion increases the risk of ischemic events after carotid artery occlusion. Neurosurgery (2008) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation. J Clin Invest (2013) 1.40
Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke (2011) 1.38
Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol (2002) 1.38
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur Heart J (2012) 1.35
Neuroendovascular management of carotid cavernous fistulae. Neurosurg Clin N Am (2009) 1.34
Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. Stroke (2013) 1.33